我们将关怀分享至世界各地

Temperature control and timely intervention are critical to ensure the integrity of pharmaceutical cargo. Even slight deviations can compromise the quality of life-saving medicines, disrupt their movement, and set companies back. For a deep-dive into the strategies and technologies that safeguard these vital shipments, read an insightful article by our pharma specialist Sebastian Steinmueller.

Time and quality control are key for pharma supply chains given the particularity of their cargo, but what role does visibility play? What exactly does visibility mean for pharma supply chains? In this research piece, see how better data can help visibility and what the future holds.

By choosing Maersk ECO Delivery Ocean, this pharma company was able to get closer to their decarbonisation goals while still delivering essential care all around the world. 

India is a global pharmaceutical powerhouse, on course to being a $450 billion industry by 2047. The country contributes to over 20% of the world's drug supply chain and manufactures over 60% of the global demand for vaccines. What makes the pharma industry tick in India? How are the latest innovations in technology changing the face of how the sector is run and the medicines transported? What supply chain challenges does it encounter?
Read our article for a comprehensive understanding of the latest developments and challenges in the Indian pharma industry.

20 年后，当我们回看全球供应链的变革，我们会把它分为两个截然不同的时期 —— 前新冠疫情时代和后新冠疫情时代。 虽然之前也曾有疫情爆发事件，但那时候跨境贸易并未像现在一样占据全球经济总值的50% 。 我们从未有过这样的供应链 —— 其中运转的部分如此之庞大，跨越全球如此之多的国家，牵涉到如此之多的利益方。 供应链从未经受过这样的压力，我们需要借助于专业学者们的理论实践及风险控制经理的灾难应急计划。

专业人员们正主动响应制药和医疗服务等领域的需求，致力于规划一个更加可靠、透明、智能的供应链。 为了推动变革，企业需要评估从生产到交付、海关、仓储设备及最终客户的整条供应链。

在此电子手册中，我们评估了时下制药和医疗物流行业的革新及未来的整体面貌。 我们重点研究了在某些关键领域，马士基通过在流程、技术和协作方面的变革，实现端到端运输的创新。

Transporting the most fragile, high-value, regulated cargo in the world is complex. Even more so when you need to roll out billions of doses of a vaccine across continents to every person on the planet. Add to that the pressures of running a supply chain focused on reducing greenhouse gas (GHG) emissions, and pharma companies could find themselves in a dilemma. Unless they add a healthy dose of shipping to their modal mix. It’s reliable, makes essential products accessible to patients around the globe, and emits less GHG emissions than most other modes of transportation, such as air transportation.